Brazil Finds a Way Around Gene Therapy’s High Price

Hi, it’s Gabriel in Sao Paulo. Brazil will soon manufacture its own cancer-fighting gene therapies to make these treatments more affordable. But first…

One of the most promising treatments for blood cancer involves reengineering immune cells to attack cancer cells. CAR-T, or chimeric antigen receptor T-cell therapy, takes cells drawn from a patient’s blood, adds a receptor gene in a lab and then reinjects the cells into the patient. A report by the American Society of Hematology found that after CAR-T treatment, three-quarters of blood cancer patients achieved remission.